ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

QNCX Quince Therapeutics Inc

1.00
-0.03 (-2.91%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Quince Therapeutics Inc QNCX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.03 -2.91% 1.00 23:00:04
Open Price Low Price High Price Close Price Previous Close
1.01 0.98 1.08 1.06 1.03
more quote information »

Recent News

Date Time Source Heading
4/01/202406:00BWQuince Therapeutics Provides Business Update and Reports..
2/22/202406:00BWQuince Therapeutics Launches Scientific Advisory Board
2/15/202415:00EDGAR2Form 8-K - Current report
2/15/202406:00BWQuince Therapeutics Appoints Former Reata Pharmaceuticals..
2/07/202415:05BWQuince Therapeutics to Present at Oppenheimer 34th Annual..
2/02/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/05/202415:01EDGAR2Form 8-K/A - Current report: [Amend]
1/04/202415:05BWQuince Therapeutics to Participate at Investor Events in..
1/03/202415:02EDGAR2Form 8-K - Current report
12/22/202315:08EDGAR2Form 8-K - Current report
12/14/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202315:06EDGAR2Form 8-K - Current report
12/07/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202312:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202316:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/24/202318:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/24/202318:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/23/202315:05EDGAR2Form 8-K - Current report
10/23/202306:00BWQuince Therapeutics Completes Acquisition of EryDel S.p.A.
9/28/202315:53DJNQuince Therapeutics to Advance Study of EryDex as FDA Lifts..
9/28/202315:05BWU.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s..
9/06/202306:18EDGAR2Form 8-K - Current report
9/06/202306:00BWQuince Therapeutics Appoints Dr. Charles S. Ryan as..
8/31/202317:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/17/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:05EDGAR2Form 8-K - Current report
8/10/202315:05BWQuince Therapeutics to Present at Sidoti Virtual Investor..
8/09/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202317:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/24/202316:56BWQuince Therapeutics rileva EryDel SpA e il suo asset di fase..
7/24/202306:16EDGAR2Form 8-K - Current report
7/24/202306:00BWQuince Therapeutics to Acquire EryDel SpA and its Phase 3..

Your Recent History

Delayed Upgrade Clock